Reneo Pharmaceuticals, Inc. - FORM S-1 - EX-23.1 - March 19, 2021

Attached files

file filename
EX-21.1 - EX-21.1 - Reneo Pharmaceuticals, Inc.d63585dex211.htm
EX-10.19 - EX-10.19 - Reneo Pharmaceuticals, Inc.d63585dex1019.htm
EX-10.18 - EX-10.18 - Reneo Pharmaceuticals, Inc.d63585dex1018.htm
EX-10.17 - EX-10.17 - Reneo Pharmaceuticals, Inc.d63585dex1017.htm
EX-10.16 - EX-10.16 - Reneo Pharmaceuticals, Inc.d63585dex1016.htm
EX-10.15 - EX-10.15 - Reneo Pharmaceuticals, Inc.d63585dex1015.htm
EX-10.14 - EX-10.14 - Reneo Pharmaceuticals, Inc.d63585dex1014.htm
EX-10.13 - EX-10.13 - Reneo Pharmaceuticals, Inc.d63585dex1013.htm
EX-10.12 - EX-10.12 - Reneo Pharmaceuticals, Inc.d63585dex1012.htm
EX-10.11 - EX-10.11 - Reneo Pharmaceuticals, Inc.d63585dex1011.htm
EX-10.10 - EX-10.10 - Reneo Pharmaceuticals, Inc.d63585dex1010.htm
EX-10.9 - EX-10.9 - Reneo Pharmaceuticals, Inc.d63585dex109.htm
EX-10.8 - EX-10.8 - Reneo Pharmaceuticals, Inc.d63585dex108.htm
EX-10.2 - EX-10.2 - Reneo Pharmaceuticals, Inc.d63585dex102.htm
EX-10.1 - EX-10.1 - Reneo Pharmaceuticals, Inc.d63585dex101.htm
EX-4.2 - EX-4.2 - Reneo Pharmaceuticals, Inc.d63585dex42.htm
EX-3.4 - EX-3.4 - Reneo Pharmaceuticals, Inc.d63585dex34.htm
EX-3.3 - EX-3.3 - Reneo Pharmaceuticals, Inc.d63585dex33.htm
EX-3.2 - EX-3.2 - Reneo Pharmaceuticals, Inc.d63585dex32.htm
EX-3.1 - EX-3.1 - Reneo Pharmaceuticals, Inc.d63585dex31.htm
S-1 - FORM S-1 - Reneo Pharmaceuticals, Inc.d63585ds1.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 19, 2021, in the Registration Statement (Form S-1) and related Prospectus of Reneo Pharmaceuticals, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

San Diego, California

March 19, 2021